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1. Introduction 
In the previous paper [I] it has been demonstrated 
that the 2’,3’Oethoxymethylene derivatives of adeno- 
sine, AMP, ADP and ATP possess trong inhibitory 
effects on the activity of hepatic adenylate cyclase. 
Ethoxymethylene-ATP (ATP-EM) was the most 
potent inhibitor from these compounds which contain 
the blocked cis-diol grouping on the ribose. This paper 
describes the mechanism of the inhibitory effect of 
ATFEM on the activity of hepatic adenylate cyclase. 
2. Materials and methods 
2’,3’0-Ethoxymethylene-ATP (ATP-EM) and 2’,3’- 
0Isopropylidene-ATP (ATP-IPI) were synthesized as 
described previously [ 11. Guanylylmidodiphosphate 
(Gpp(NH)p) was a product of Bohringer, glucagon 
was supplied by Eli Lilly, neutral aluminium oxide 
for chromatographic adsorption analysis according 
to Brockmann (act. II) was a product of Reanal, 
Hungary, and [o-““PI ATP, trisodium salt (3-10 
Ci/mmol) was supplied by the Radiochemical Centre, 
Amersham. Other chemicals used were from the 
sources described earlier [ 21. 
The enzyme preparation for adenylate cyclase 
activity determination was made by a mild homogeni- 
North-Holland Publishing Company - Amsterdam 
zation of 0.5 g rat liver in 5 ml ice-cold 75 mM Tris- 
HCl buffer, pH 7.8, with 26 mM MgS04 and 1 mM 
EDTA and subsequent centrifugation of the sample for 
2 min at 900 X g; the sediment fraction was suspended 
in 5- 10 ml of the same homogenization medium 
and it was considered as a crude plasma membranes 
fraction. A 20 ~1 fraction, corresponding to 40-80 pg 
protein [3], was used for adenylate cyclase assay. In 
experiments with preincubation, 1 ml plasma membrane 
fraction was incubated with additions for 10 min at 
37°C. Then the samples were cooled, centrifuged at 
0-4°C for 5 min at 900 X g, resuspended in 1 ml of 
the above-described homogenization medium, and the 
whole procedure repeated three times. Volumes (20 dul) 
of this washed plasma membranes fraction from 
samples after preincubation were again used for adenyl- 
ate cyclase assay. 
The activity of adenylate cyclase was determinea 
according to Ramachandran [4] with modifications 
described earlier [2]. The final composition of the 
incubation mixture was: 0.1 mM ATP, 30 mM 
Tris-HCl, pH 7.8, 2 mM cyclic AMP, 10.4 mM Mg2+, 
1 mM K’, 0.4 mM EDTA, 5 mM phosphoenolpyruvate, 
phosphoenol pyruvate kinase 40 pg/ml and myokinase 
20 pg/ml. The 32P radioactivity was measured by 
Cerenkov’s radiation [ 51. The results are presented in 
pica- or nano moles of cyclic AMP produced by 1 mg 
enzyme protein/l 0 min incubation. Given values are 
mean f SE of two or three experiments. 
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3. Results 
The inhibitory effect of ATP-EM was tested on the 
basal activity of hepatic adenylate cyclase and the 
activity of the same enzyme stimulated by glucagon 
or Gpp(NH)p or sodium fluoride. The results in table1 
show that percentage inhibition of adenylate cyclase 
activity by increasing concentrations of ATP-EM 
(0.03-l .O mM) was the same regardless to the enzyme 
activity and to the type of the stimulatory agent used. 
Figure 1 shows that the nonproductive substrate 
analogue ATP-EM which cannot be converted to cyclic 
AMP by adenylate cyclase competitively inhibits the 
interaction of ATP with the enzyme stimulated by 
glucagon. In the presence of 10.4 mM Mg2’ and 
0.4 mM EDTA, linear double reciprocal plots were 
obtained at pH 7.8. The kinetic constants are summa- 
rized in the inserted table. The inhibitory effects of 
ATP-EM are purely competitive at 32 PM and 100 PM 
concentrations while at 320 PM concentration the 
effects appear to be of noncompetitive type of inhibi- 
tion as it is seen from the drop of Vmax, The Ki for 
competitive antagonism is 25-30 PM; thus Ki is only 
l/4-1/3 of Km for ATP. These data indicate that the 
affinity of the active site for ATP-EM is greater than 
that for the natural substrate. 
The aim of the following experiments was to 
determine whether ATP-EM inhibits the activation 
process of adenylate cyclase or whether this drug can 
antagonize the activity of the enzyme in the already 
active state. Following the pretreatment with a combina- 
tion of Gpp(NH)p and glucagon, and extensive washing 
of hepatic membranes, the enzyme displayed 5-7-times 
higher activity than the enzyme preincubated in the 
absence of these stimulatory drugs. The latter enzyme 
could be activated by the addition of glucagon or 
Gpp(NH)p or sodium fluoride to the assay system. 
However, this stimulated activity did not reach the 
values of activity of the enzyme preincubated in the 
presence of Gpp(NH)p plus glucagon. The enzyme in a 
persistent active state [6] could not be further 
activated by the addition of glucagon or Gpp(NH)p 
or sodium fluoride to the assay system. On the contrary 
the addition of sodium fluoride partially reduced the 
enzyme activity (table 2). 
Figure 2 compares the inhibitory effect of ATFEM 
with that of another nonproductive substrate ATP-IPI 
on cyclic AMP production by hepatic adenylate cyclase 
preparations in a persistent active state elicited by the 
combined actions of Gpp(NH)p and glucagon. The 
inhibitory effect of ATP-EM was stronger than the 
effect of ATP-IPI. 
The action of ATP-EM on the activation process 
of the combination of Gpp(NH)p and glucagon during 
the time of enzyme preincubation was tested in order 
to determine whether the inhibititory effects of this 
nonproductive substrate are confined to the binding 
site of ATP at the catalytic unit of adenylate cyclase 
or whether this drug also acts on the nucleotide regu- 
latory site [7]. ATP-EM added to the adenylate cyclase 
Table 1 
Inhibitory effect of ATP-EM on basal activity of hepatic adenylate cyclase and activity 
stimulated by glucagon or Gpp(NH)p or sodium fluoride 
ATP-EM 
(ctM) 
. 
Adenylate cyclase activity (%) 
Nonea Glucagonb 
(1 IJM) 
GPPWWP~ 
(0.1 mM) 
NaFd 
(10 mM) 
None 100 100 100 100 
32 61+_ 6 59 +_ 6 60t 1 59t 1 
100 35 c 2 37 * 1 34 * 2 35 * 1 
320 13+4 9+1 13 * 0 13* 2 
1000 4+2 2kO 4?1 3+0 
a-dpmol cyclic AMP formed/mg protein/l0 min 
a 61+11 
b300 + 42 
c334 r 2 
d432 f 11 
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Fig.1. Double reciprocal plots of activity versus substrate (ATP) for hepatic adenylate cyclase stimulated by 1 PM glucagon; 
inhibitor ATP-EM was used in concentrations 32 fiM, 100 PM and 320 bM. Km and Vmax are given in the inserted table. 
preparations during the preincubation without are not connected with its action on the nucleotide 
Gpp(NH)p did not lead to the activation of the enzyme regulatory site of the enzyme. 
(results not shown). The results in table 2 show that 
the production of the persistent active state due to a 
combined actions of Gpp(NH)p and glucagon was 4. Discussion 
not reduced by the addition of ATP-EM during the 
time of preincubation. These results indicate that the The strong inhibitory effect of ATP-EM and other 
inhibitory effects of ATP-EM on adenylate cyclase adenine derivatives with blocked cis-diol grouping on 
Table 2 
The effect of ATP-EM on the activation of hepatic adenylate cyclase by combined 
actions of Gpp(NH)p and glucagon during the preincubation of the enzyme 
Adenylate cyclase Preincubation additions 
assay additions _____ 
None Gpp(NH)P (0.1 mW 
+ Glucagon (1 PM) 
CPPWDP (0.1 mM) 
+ Glucagon (1 PM) 
+ ATP-EM (1 mM) 
Basala 77 * 16 412 + 12 
Glucagon (1 PM)~ 165 f 18 397 f 26 
Gpp(NH)p (0.1 mM)’ 247 * 3 413* 5 
NaF (10 mM)d 163 k 6 349 + 3 
a-dpmol cyclic AMP formed/mg protein/l0 min 
502k 12 
458 k 10 
515 + 25 
398 + 10 
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Drug 
Fig.2. The inhibitory effect of ATP-EM and ATP-IPI on the 
persistent active state of hepatic adenylate cyclase due to a 
combined effect of 1 PM glucagon and 0.1 mM Gpp(NH)p 
during 10 min preincubation (a); preincubation without 
additions ($); inhibitory drugs ATP-EM (n) and ATP-IPI 
(0) were added to the adenylate cyclase assay system. 
the ribose on the activity of hepatic adenylate cyclase 
was described in the previous paper [ 11. This inhibitory 
effect can be demonstrated both on the basal adenylate 
cyclase activity and on the enzyme activity stimulated 
by glucagon or Gpp(NH)p or sodium fluoride. These 
results indicate that the site of action of these inhibi- 
tory drugs is distal to the site of action of the stimu- 
lation agent, i.e, most probably at the binding site for 
ATP on the catalytic unit of adenylate cyclase. Direct 
evidence for this hypothesis is presented in this paper. 
Quantitative analysis of the inhibitory effects of 
ATFEM on basal activity of hepatic adenylate cyclase 
as well as on enzyme activity stimulated by glucagon 
or Gpp(NH)p or sodium fluoride revealed the equal 
percentage-inhibition of all these states of adenylate 
cyclase activity (table 1). Further indication for the 
action of ATP-EM at the active site of the catalytic 
unit of adenylate cyclase stems from the kinetic 
studies with glucagon-stimulated hepatic adenylate 
cyclase (fig.1). It is as evident from the data of these 
experiments, presented as double reciprocal plots of 
activity versus substrate, that ATP-EM in 32 PM 
and 100 E.IM concentrations revealed pure compe- 
titive antagonistic effects with the action of ATP, 
while at 320 PM concentrations the type of inhibition 
was noncompetitive. The affinity of active site for 
ATP-EM was 3-4 times greater than that for ATP 
alone. 
In the second part of this study we investigated 
whether ATP-EM possesses, in addition to the 
competitive inhibitory action on the catalytic site, 
any effect on the nucleotide regulatory site of the 
enzyme studied. It is known that ATP, in addition 
to its effects as substrate, interacts in high concentra- 
tions also with the nucleotide regulatory site [7], 
which preferentially reacts with GTP and its analogues 
[8]. The absence of any stimulatory (data not shown) 
or inhibitory effects of ATP-EM on the production 
of the persistently active state, due to enzyme prein- 
cubation with Gpp(NH)p plus glucagon (table 2), may 
be considered as crucial evidence indicating that the 
strong inhibitory effects of ATP-EM on adenylate 
cyclase are not connected with its action on the 
nucleotide regulatory site. 
In summary, it may be concluded that ATP-EM, 
and probably also other adenosine derivatives with a 
blocked cis-diol grouping on the ribose, like ATP-IPI, 
possesses a strong competitive inhibitory effect, with 
respect to ATP, on the catalytic site of adenylate 
cyclase. 
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